Asthma is a lung chronic disease. involving the airways in the lungs. It is characterized by reversible obstruction and hyper-responsiveness of the airways with both of these physiological abnormalities occurring on a background of airway inflammation. Coughing, episodes of wheezing, chest tightness, and shortness of breath are the main symptoms.
R.G.L leads this international and competitive phase 3 study in Israel to prove the safety of therapeutic molecule in Asthma, as it has been mandated by a biotechnology company.